| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |